Citation Impact
Citing Papers
Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)
2005
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
miR-15 and miR-16 induce apoptosis by targeting BCL2
2005 Standout
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
2002 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
The Ensembl Variant Effect Predictor
2016 Standout
The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins
2004
Mutations in the NF-κB signaling pathway: implications for human disease
2006
Coexpression of BMI-1 and EZH2 Polycomb Group Genes in Reed-Sternberg Cells of Hodgkin’s Disease
2000
Stability of Checkpoint Kinase 2 Is Regulated via Phosphorylation at Serine 456
2007
The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression
2001
Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells
2017 Nature
Epigenetics: A Landscape Takes Shape
2007 Standout
Interaction Codes within the Family of Mammalian Phox and Bem1p Domain-containing Proteins
2003
Oncogenic potential of a C.eleganscdc25 gene is demonstrated by a gain-of-function allele
2002
Cell-cycle checkpoints and cancer
2004 StandoutNature
Chk1 and Chk2 kinases in checkpoint control and cancer
2003
Applying the principles of stem-cell biology to cancer
2003
Polycomb silencers control cell fate, development and cancer
2006
The biology and management of non-small cell lung cancer
2018 StandoutNature
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations
2009
Cancer Metastasis: Building a Framework
2006 Standout
Fundamental Cellular Processes Do Not Require Vertebrate-specific Sequences within the TATA-binding Protein
2003 StandoutNobel
The emerging role of lncRNAs in cancer
2015 Standout
Shared Principles in NF-κB Signaling
2008 Standout
Lung Cancer
2008 Standout
Selective Transport of α-Mannosidase by Autophagic Pathways
2010 StandoutNobel
Dual mode of degradation of Cdc25 A phosphatase
2002
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Cellular Senescence in Cancer and Aging
2007 Standout
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
2017 Standout
Selective Transport of α-Mannosidase by Autophagic Pathways
2010 StandoutNobel
The Human Transcription Factors
2018 Standout
A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells
2006 Standout
Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage
2003 StandoutNatureNobel
Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors
2005 Standout
The Epigenomics of Cancer
2007 Standout
Hypermethylation of tumor suppressor genes in cancer
1999
Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation
1999
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
The Mammalian Epigenome
2007 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
The role of enhancers in cancer
2016
Bmi1, stem cells, and senescence regulation
2004
Identification and expansion of human colon-cancer-initiating cells
2006 StandoutNature
The polycomb group protein EZH2 is involved in progression of prostate cancer
2002 StandoutNature
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma
2003
Chk2 Oligomerization Studied by Phosphopeptide Ligation
2008 StandoutNobel
Polycomb, Epigenomes, and Control of Cell Identity
2003
Cdc7-Dbf4 and the Human S Checkpoint Response to UVC
2007 StandoutNobel
CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin?
2007
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
2000 Standout
Stem Cells and Cancer
2004 Standout
Anaplastic lymphoma kinase as a therapeutic target
2012
MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B‐cell lymphomas
2007
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
2005 StandoutNature
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
2007 Standout
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
2006
The PI3K Pathway in Human Disease
2017 Standout
Identification of human brain tumour initiating cells
2004 StandoutNature
Cancer-related inflammation
2008 StandoutNature
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
2010 StandoutNature
The cancer genome
2009 StandoutNature
Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis
2000
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes
2012 StandoutNobel
ATG Systems from the Protein Structural Point of View
2009 StandoutNobel
Therapeutic Targeting of Anaplastic Lymphoma Kinase in Lung Cancer: A Paradigm for Precision Cancer Medicine
2015
Targeting ALK: Precision Medicine Takes on Drug Resistance
2017
Inhibitors of the anaplastic lymphoma kinase
2012
Cell cycle deregulation in B-cell lymphomas
2003
Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia
2002
Cancer Genome Landscapes
2013 StandoutScience
Chromatin-association of the Polycomb group protein BMI1 is cell cycle-regulated and correlates with its phosphorylation status
1999
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
2004 Standout
ATM mutations are associated with inactivation of theARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma
2002
Absence of Apparent Phenotype in Mice Lacking Cdc25C Protein Phosphatase
2001
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
2004 StandoutNobel
Lenalidomide efficacy in activated B ‐cell‐like subtype diffuse large B ‐cell lymphoma is dependent upon IRF 4 and cereblon expression
2012
The Arf/p53 Pathway in Cancer and Aging
2008
t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia
2000
Works of Sı́lvia Beà being referenced
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
2005
Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan
2015
c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin’s lymphomas
1999
Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines
2006
Diversity of Genomic Breakpoints in TFG-ALK Translocations in Anaplastic Large Cell Lymphomas
2002
INK4a/ARFLocus Alterations in Human Non-Hodgkin's Lymphomas Mainly Occur in Tumors with Wild-Type p53 Gene
2000
Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.
1999
CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas
2002
BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas.
2001
ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances
2002
CDK4 and MDM2 Gene Alterations Mainly Occur in Highly Proliferative and Aggressive Mantle Cell Lymphomas with Wild-type INK4a/ARF Locus
2005
p16INK4a Gene Inactivation by Deletions, Mutations, and Hypermethylation Is Associated With Transformed and Aggressive Variants of Non-Hodgkin's Lymphomas
1998
Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
2006
TRK-Fused Gene (TFG) Is a New Partner of ALK in Anaplastic Large Cell Lymphoma Producing Two Structurally DifferentTFG-ALK Translocations
1999
cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas.
1998
cdc25a and the splicing variant cdc25b2, but not cdc25B1, -B3 or -C, are over-expressed in aggressive human non-Hodgkin's lymphomas
2000
Non-coding recurrent mutations in chronic lymphocytic leukaemia
2016 Nature
Clinicopathologic Significance and Prognostic Value of Chromosomal Imbalances in Diffuse Large B-Cell Lymphomas
2004